Consistent with the reduced TWIST1 levels in breast cancer, re-expression of miR-720 upregulated epithelial markers (E-cadherin and β-catenin) and downregulated mesenchymal markers (N-cadherin, fibronectin, vimentin and matrix metal- loproteinase-2).